17 participants
Sorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-07-27
- Start Date:
- 2005-04-30
- Completion:
- 2010-05-31
Conditions
- Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter
- Recurrent Bladder Cancer
- Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
- Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
- Stage III Bladder Cancer
- Stage IV Bladder Cancer
- Transitional Cell Carcinoma of the Bladder
Interventions
- DRUG
- OTHER